Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation
Publication: Annals of Internal Medicine
Volume 128, Number 10
Abstract
Background:
Recurrence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection after liver transplantation is a clinical problem. Polyclonal immunoglobulins against hepatitis B surface antigen (HBIGs) prevent the recurrence of HBV infection, but no effective prophylaxis is available for HCV infection. Before screening of blood donors was introduced in France, HBIGs may have contained antibody to HCV (anti-HCV).
Objective:
To determine the influence of HBIG on the occurrence of hepatitis C after liver transplantation before and after 1990.
Design:
Retrospective cohort study.
Setting:
Liver transplantation unit of a university hospital.
Patients:
428 consecutive patients who had liver transplantation because of cirrhosis between 1984 and 1994.
Measurements:
Detection of serum HCV RNA before and 1 year after transplantation and findings on liver graft biopsy.
Results:
Among the 218 patients who had HCV infection before transplantation, the incidence of HCV viremia after transplantation was lower in those receiving HBIG than in those not receiving HBIG (25 of 46 patients [54%] compared with 162 of 172 patients [94%]; P < 0.001). In patients receiving HBIG, the incidence of HCV viremia after transplantation was lower among those who had transplantation before March 1990 than among those who had transplantation after this date (15 of 33 patients [45%] compared with 10 of 13 patients [77%]; P = 0.05). Among the 210 patients without HCV infection before transplantation, acquired infection was significantly less frequent in those receiving HBIG than in those not receiving HBIG (18 of 68 patients [26%] compared with 40 of 86 patients [47%]; P < 0.001). Passively transmitted anti-HCV was transiently detected in patients receiving HBIG before March 1990. Multivariate analysis in patients with HCV infection before transplantation showed that the absence of HBIG and transplantation after March 1990 were independent significant risk factors for chronic hepatitis C after transplantation.
Conclusions:
Polyclonal immunoglobulins that are treated for viral decontamination and contain anti-HCV could prevent HCV infection.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Wright TL, Donegan E, Hsu H, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992; 103:317-22.
2.
Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C infection after liver transplantation. Hepatology. 1994; 20:1137-43.
3.
Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993; 329:1842-7.
4.
Farci P, Alter HJ, Govindarajan S, Wong D, Engle R, Lesniewski RR, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 1992; 258:135-40.
5.
Yap PL, McOmish F, Webster AD, Hammarstrom L, Smith CI, Bjorkander J, et al. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol. 1994; 21:455-60.
6.
Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinernia after treatment with contaminated immune globulin. N Engl J Med. 1994; 331:1607-11.
7.
Lefrere J, Mariotti M, Trepo C, Li J, Lunel F, Frangeul L, et al. Testing for HCV-RNA in commercial intravenous immunoglobulins [Letter]. Lancet. 1993; 341:835.
8.
Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet. 1991; 337:813-5.
9.
Randomised trial comparing tacrolimus (FK506) to cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet. 1994; 344:423-8.
10.
Farges O, Ericzon BG, Bresson-Hadni S, Lynch SV, Hockerstedt K, Houssin D, et al. Randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter study. Transplantation. 1994; 58:891-8.
11.
Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology. 1983; 3:279-84.
12.
Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89:1361-5.
13.
Kwok S, Higushi R. Avoiding false positives with PCR. Nature. 1989; 339:237-8.
14.
Knodell R, Conrad ME, Ginsberg AL, Bell CJ. Efficacy of prophylactic γ-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet. 1976; 1:557-61.
15.
Sanchez-Quijano A, Pineda JA, Lissen E, Leal M, Diaz-Torres MA, De Pesquera F, et al. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet. 1988; 1:1245-9.
16.
Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Nest GV, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A. 1994; 91:1294-8.
17.
Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol. 1994; 68:1494-500.
18.
Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A. 1994; 91:7792-6.
19.
Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, et al. Effect of immune globulin on the prevention of experimental hepatitis C infection. J Infect Dis. 1996; 173:822-8.
20.
Alberti A, Pontisso P, Chemello L, Fattovitch G, Benvegnu L, Belussi F, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol. 1995; 22:38-41.
21.
Feray C, Zignego AL, Samuel D, Bismuth A, Tiollais P, Bismuth H, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation. 1990; 49:1155-8.
22.
Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, et al. Incidence of reinfection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology. 1996; 5:569-72.
23.
Nowak T, Gregersen J, Klockmann U, Cummins LB, Hilfenhaus J. Virus safety of human immunoglobulins: efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure. J Med Virol. 1992; 36:209-16.
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 128 • Number 10 • 15 May 1998
Pages: 810 - 816
History
Published in issue: 15 May 1998
Published online: 15 August 2000
Keywords
- Abdominal surgery
- Blood
- Blood banks
- Blood plasma
- Body fluids
- Diagnostic medicine
- Drugs
- Genetics
- Health care
- Health care facilities
- Hepatitis C
- Hospital medicine
- Infectious hepatitis
- Liver diseases
- Liver transplantation
- Pathology and laboratory medicine
- Pharmacology
- Prevention, policy, and public health
- RNA
- Sepsis
- Signs and symptoms
- Steroids
- Surgery
- Transplantation
Copyright
© 1998 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation. Ann Intern Med.1998;128:810-816. doi:10.7326/0003-4819-128-10-199805150-00003
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation. Ann Intern Med.1998;128:810-816. doi:10.7326/0003-4819-128-10-199805150-00003
View More
Get Access
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.